School of Public Health and Management, Research Center for Medicine and Social Development, Collaborative Innovation Center of Social Risks Governance in Health, Chongqing Medical University, No. 1 Yixueyuan Road Yuzhong District, Chongqing, 400016, China.
Environ Health Prev Med. 2019 Jul 27;24(1):50. doi: 10.1186/s12199-019-0805-9.
Polycyclic aromatic hydrocarbons (PAHs) are widely found in the environment, and comparing to adults, children are more vulnerable to PAHs exposure. Urinary metabolites of PAHs are used as preferred biomarkers to estimate the PAHs exposure. Systematic review on the internal exposure level of children and adolescents is rare. We aimed to calculate the internal exposure levels of PAHs in children and adolescents and compare the levels of PAHs internal exposure in various children groups. We searched PubMed, OVID, Web of Science, EBSCO, ACS, and four Chinese databases, and all studies examining the urinary concentrations of PAHs in children and adolescent were identified. The total exposure level of 11 PAHs metabolites were pooled. Standard mean difference (SMD) and 95% confidence intervals (CIs) of PAHs urinary concentration were calculated and pooled by RevMan5.3 to compare the exposure levels of different children groups. We found that 1-OHPyr, 2-OHNap, 2-OHFlu, 3-OHPhe, and 4-OHPhe were five PAHs metabolites most commonly studied in existing studies in children, and their total exposure levels were 0.38 ± 0.98, 2.32 ± 4.83, 0.81 ± 1.54, 0.09 ± 0.14, 0.03 ± 0.10 μmol/mol creatinine, respectively. The meta-analysis showed that the levels of 1-OHPyr were higher in higher environmental exposure group (SMD = 0.21, 95% CI = 0.030.40), ETS exposure group (SMD = 0.31, 95% CI = 0.080.54), and 611 years group (SMD = 0.16, 95% CI = 0.090.24); the level of 2-OHNap (SMD = 0.27, 95% CI = 0.010.53) was higher in higher environmental exposure group; however, the levels of 3-OHPhe (SMD = - 0.34, 95% CI = - 0.57- 0.12) and 4-OHPhe (SMD = - 0.48, 95% CI = - 0.69- 0.28) were higher in lower environmental exposure group. The levels of 1-OHPyr (SMD = - 0.01, 95% CI = - 0.110.10) and 2-OHNap (SMD = 0.01, 95% CI = - 0.20~0.22) were not statistically different between boys and girls. In conclusions, we found that the internal diversity of PAHs existed in children and adolescents, and the level of 1-OHPyr in children and adolescents was in higher status compared with non-occupational people who do not smoke.
多环芳烃(PAHs)广泛存在于环境中,与成年人相比,儿童更容易受到 PAHs 的暴露。PAHs 的尿代谢物被用作估计 PAHs 暴露的首选生物标志物。系统评价儿童和青少年的内部暴露水平较为少见。我们旨在计算儿童和青少年体内 PAHs 的内暴露水平,并比较不同儿童群体的 PAHs 内暴露水平。我们检索了 PubMed、OVID、Web of Science、EBSCO、ACS 和四个中文数据库,并确定了所有研究儿童和青少年尿液中 PAHs 浓度的研究。汇总了 11 种 PAHs 代谢物的总暴露水平。采用 RevMan5.3 计算并汇总 PAHs 尿浓度的标准均数差(SMD)和 95%置信区间(CI),以比较不同儿童群体的暴露水平。我们发现,1-OHPyr、2-OHNap、2-OHFlu、3-OHPhe 和 4-OHPhe 是目前儿童研究中最常研究的五种 PAHs 代谢物,其总暴露水平分别为 0.38±0.98、2.32±4.83、0.81±1.54、0.09±0.14 和 0.03±0.10μmol/mol 肌酐。荟萃分析显示,在高环境暴露组(SMD=0.21,95%CI=0.030.40)、ETS 暴露组(SMD=0.31,95%CI=0.080.54)和 611 岁组(SMD=0.16,95%CI=0.090.24)中,1-OHPyr 水平较高;2-OHNap 水平较高(SMD=0.27,95%CI=0.010.53);然而,在低环境暴露组中,3-OHPhe(SMD=-0.34,95%CI=-0.57-0.12)和 4-OHPhe(SMD=-0.48,95%CI=-0.69-0.28)水平较高。1-OHPyr(SMD=-0.01,95%CI=-0.110.10)和 2-OHNap(SMD=0.01,95%CI=-0.20~0.22)的水平在男孩和女孩之间没有统计学差异。总之,我们发现儿童和青少年体内的 PAHs 存在内在差异,与不吸烟的非职业人群相比,儿童和青少年的 1-OHPyr 水平较高。